Skip to content

Long-acting male contraceptive, reportedly efficient for a minimum of 2 years, according to biotechnology company's declaration.

Injectable Male Hormonal Barrier, ADAM, Efficient After Two Years in Initial Human Testing

Long-acting male contraceptive, reportedly efficient for a minimum of 2 years, according to biotechnology company's declaration.

Buzz: Male Contraceptive ADAM Moves Closer to Revolutionizing Reproductive Health

The game is a changin' y'all! A breakthrough in the contraceptive world is on the horizon, and it's all thanks to a badass biotech company called Contraline. They're developing a mind-blowing, non-hormonal, and reversible male contraceptive called ADAM. And the latest news? It's been effective and safe two frickin' years into the first human clinical trial.

In a ( manufactur' rental ) today, Contraline dropped the bomb that these findings show their water-soluble hydrogel implant, ADAM, has the potential to last two years, just like we've all been dreamin' about. The best part? You can still do the wild thing, 'cause ADAM allows for the ol' ball-bustin' action.

Alexander Pastuszak, Contraline's Chief Medical Officer, couldn't contain his excitement in the release, saying, "Our goal was to give a quality option to the fellas, and these findings show that ADAM is the real deal. We're optimistic about its safety, efficacy, and reversibility, and its potential to offer couples greater reproductive control."

Now, ADAM works by blocking those swimmers right where they come out, but don't worry about those awkward, messy condoms or permanent vasectomies. Just imagine the freedom!

But hang on a sec, 'cause this ain't your average condom situation. In a past ( rental press release ), Contraline claimed that ADAM causes a 99.8 to 100% reduction in the count of those wriggly little swimmers within a month of the implantation.

And the results confirm it, ya'll. They're "one step closer to transformin' the contraceptive scene," said Kevin Eisenfrats, co-founder and CEO of Contraline. It looks like they might just reach the same level of efficacy as long-acting female contraceptives like IUDs, but for the fellas this time!

So far, the good news is the trial participants haven't reported any serious adverse events or unexpected safety concerns, but the researchers will continue to monitor them at 12-, 15-, 18-, and 21-month marks using both lab testing and at-home sperm tests. Plus, they've got the green light to start the study's second phase!

But, as Jon Oatley, a professor at Washington State University's School of Molecular Biosciences, pointed out to The Guardian, "We ain't seen no public data yet confirmin' the implant is reversible, and researchers still don't know the long-term effects of blockin' the vasa deferentia." He also suggested most men would probably prefer a pill or patch over surgery.

But, hey, guess what? Back in 2017 to 2019, about 10.4% of women aged 15 to 49 used long-acting reversible contraceptives like IUDs or those implants that need procedures. That's barely four points behind the pill. If ADAM really is the real deal, maybe a significant number of men will hop on the long-term efficacy train instead of the short-term usefulness of other contraceptives.

So, buckle up, folks! This could be the start of a brand-new era in reproductive health for the men out there. Time to take control!

The advancements in reproductive health continue as we move closer to the future, with the potential for a game-changing non-hormonal male contraceptive, ADAM, made by Contraline. This water-soluble hydrogel implant could provide a quality option for men, potentially lasting two years.

The efficacy of ADAM has shown a remarkable reduction in sperm count, registering 99.8% to 100% within a month of implantation, similar to long-acting female contraceptives.

If successful, ADAM might encourage a significant shift in male contraceptive use, paralleling the 10.4% adoption rate of long-acting reversible contraceptives among women in 2017 to 2019.

However, it's essential to await further research, including data confirming its reversibility and long-term effects on health, as well as understanding the preferences of men for various delivery methods. The future of men's health and wellness-and overall reproductive health-might be redefined by ADAM's success.

Read also:

    Latest